Jubilant Biosys Limited, a prominent player in the biopharmaceutical industry, is headquartered in India and operates extensively across North America, Europe, and Asia. Founded in 2007, the company has established itself as a leader in drug discovery and development services, catering to a diverse range of therapeutic areas including oncology, central nervous system disorders, and infectious diseases. Jubilant Biosys offers a unique blend of integrated services, from early-stage research to clinical development, which distinguishes it in a competitive market. The company’s commitment to innovation and quality has earned it a strong market position, with notable achievements in collaborations with global pharmaceutical firms. With a focus on advancing healthcare solutions, Jubilant Biosys continues to drive progress in the biopharmaceutical landscape.
How does Jubilant Biosys Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Jubilant Biosys Limited's score of 18 is lower than 95% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Jubilant Biosys Limited, headquartered in India, currently does not have publicly available carbon emissions data for recent years. As such, specific figures regarding their carbon footprint, including Scope 1, 2, or 3 emissions, are not disclosed. In the absence of concrete emissions data, it is important to note that the company has not outlined any specific reduction targets or commitments to the Science Based Targets initiative (SBTi) or similar climate pledges. This lack of publicly stated climate commitments may reflect a broader industry context where many companies are increasingly focusing on sustainability and carbon reduction strategies. As the global emphasis on climate action intensifies, it will be crucial for Jubilant Biosys Limited to establish clear emissions reduction goals and transparency in their environmental impact to align with industry standards and stakeholder expectations.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Jubilant Biosys Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.